- Upregulation of CYP2S1 by oxaliplatin is associated with p53 status in colorectal cancer cell linesYang Chao; Zhou Qian; Li Minle; Tong Xuemei; Sun Jiayi; Qing Yin; Sun Liya; Yang Xuhan; Hu Xiaowen; Jiang Jie; Yan Xiaomei; He Lin; Wan ChunlingScientific Reports, 2016, 6: 33078.
- RNA-seq identifies determinants of oxaliplatin sensitivity in colorectal cancer cell linesLi Xin Xiang; Peng Jun Jie; Liang Lei; Huang Li Yong; Li Da Wei; Shi De Bing; Zheng Hong Tu; Cai San JunInternational Journal of Clinical and Experimental Pathology, 2014, 7(7): 3763.
- Pharmacogenomic Analysis Identifies Increased Efficacy of Oxaliplatin in ABCB1 Overexpressing TumorsAnh-Nhan PhamJournal of Pharmacogenomics & Pharmacoproteomics, 2012, 03(04).
期刊论文
WBSCR22 confers oxaliplatin resistance in human colorectal cancer
23阅读
